DK1601694T3 - Anvendelser af IL23-antagonister, relaterede reagenser - Google Patents

Anvendelser af IL23-antagonister, relaterede reagenser

Info

Publication number
DK1601694T3
DK1601694T3 DK04718824T DK04718824T DK1601694T3 DK 1601694 T3 DK1601694 T3 DK 1601694T3 DK 04718824 T DK04718824 T DK 04718824T DK 04718824 T DK04718824 T DK 04718824T DK 1601694 T3 DK1601694 T3 DK 1601694T3
Authority
DK
Denmark
Prior art keywords
antagonists
related reagents
methods
reagents
tumors
Prior art date
Application number
DK04718824T
Other languages
English (en)
Inventor
Terrill K Mcclanahan
Martin Oft
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of DK1601694T3 publication Critical patent/DK1601694T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
DK04718824T 2003-03-10 2004-03-09 Anvendelser af IL23-antagonister, relaterede reagenser DK1601694T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45367203P 2003-03-10 2003-03-10
PCT/US2004/007198 WO2004081190A2 (en) 2003-03-10 2004-03-09 Uses of il-23 agonists and antagonists; related reagents

Publications (1)

Publication Number Publication Date
DK1601694T3 true DK1601694T3 (da) 2009-12-14

Family

ID=32990805

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04718824T DK1601694T3 (da) 2003-03-10 2004-03-09 Anvendelser af IL23-antagonister, relaterede reagenser

Country Status (23)

Country Link
US (4) US7282204B2 (da)
EP (2) EP1601694B1 (da)
JP (4) JP4605798B2 (da)
CN (1) CN1759123B (da)
AT (1) ATE440864T1 (da)
AU (2) AU2004219625B9 (da)
BR (1) BRPI0408247A (da)
CA (1) CA2518262C (da)
CL (1) CL2004000467A1 (da)
CY (1) CY1109468T1 (da)
DE (1) DE602004022781D1 (da)
DK (1) DK1601694T3 (da)
ES (1) ES2330220T3 (da)
HK (1) HK1076477A1 (da)
MX (1) MXPA05009717A (da)
NO (1) NO20054630D0 (da)
NZ (2) NZ541898A (da)
PL (1) PL1601694T3 (da)
PT (1) PT1601694E (da)
SI (1) SI1601694T1 (da)
TW (2) TWI357336B (da)
WO (1) WO2004081190A2 (da)
ZA (1) ZA200506879B (da)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020137890A1 (en) * 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
DK1576011T3 (da) * 2002-10-30 2009-11-30 Genentech Inc Inhibering af IL-17 produktion
WO2004081190A2 (en) * 2003-03-10 2004-09-23 Schering Corporation Uses of il-23 agonists and antagonists; related reagents
US7247711B2 (en) 2003-05-09 2007-07-24 Centocor, Inc. IL-23p40 specific antibody
AU2005215527B2 (en) * 2004-02-17 2011-04-07 Merck Sharp & Dohme Corp. Methods of modulating IL-23 activity; related reagents
CA2557633A1 (en) * 2004-03-05 2005-09-22 Archemix Corp. Aptamers to the human il-12 cytokine family and their use as autoimmune disease therapeutics
US20060193821A1 (en) * 2004-03-05 2006-08-31 Diener John L Aptamers to the human IL-12 cytokine family and their use as autoimmune disease therapeutics
AR051444A1 (es) 2004-09-24 2007-01-17 Centocor Inc Proteinas derivadas de inmunoglobulina especifica de il-23p40, composiciones, epitopos, metodos y usos
WO2006068987A2 (en) * 2004-12-20 2006-06-29 Schering Corporation Uses of il-23 antagonists in the treatment of diabetes mellitus
CA2612785A1 (en) * 2005-06-30 2007-01-11 Archemix Corp. Polynucleotides and polypeptides of the il-12 family of cytokines
AU2012258409B2 (en) * 2005-06-30 2016-01-07 Centocor, Inc. Anti-IL-23 antibodies, compositions, methods and uses
EP3501537A1 (en) 2005-06-30 2019-06-26 Janssen Biotech, Inc. Anti-il23 antibodies, compositions, methods and uses
DE602006015830D1 (de) * 2005-08-25 2010-09-09 Lilly Co Eli Anti-il-23-antikörper
CA2620802A1 (en) 2005-08-31 2007-03-08 Schering Corporation Engineered anti-il-23 antibodies
DK1933869T3 (da) 2005-09-01 2010-03-01 Schering Corp Anvendelse af IL-23- og IL-17-antagonister til behandling af autoimmun øjenbetændelsessygdom
DK1971366T3 (da) * 2005-12-29 2014-10-13 Janssen Biotech Inc Humane anti-IL-23-antistoffer, sammensætninger, fremgangsmåder og anvendelser
US7910703B2 (en) 2006-03-10 2011-03-22 Zymogenetics, Inc. Antagonists to IL-17A, IL-17F, and IL-23P19 and methods of use
US7790862B2 (en) 2006-06-13 2010-09-07 Zymogenetics, Inc. IL-17 and IL-23 antagonists and methods of using the same
EP1882699A1 (en) * 2006-07-27 2008-01-30 Heinfried Radeke Regulation of interleukin-23
TWI426918B (zh) * 2007-02-12 2014-02-21 Merck Sharp & Dohme Ｉｌ-２３拮抗劑於治療感染之用途
CN103396489A (zh) 2007-02-23 2013-11-20 默沙东公司 工程改造的抗IL-23p19抗体
CA2678749C (en) 2007-02-23 2018-03-13 Schering Corporation Engineered anti-il-23p19 antibodies
KR20100014568A (ko) 2007-02-28 2010-02-10 쉐링 코포레이션 가공된 항-ｉｌ-23ｒ 항체
CA2679400A1 (en) 2007-02-28 2008-09-04 Schering Corporation Combination therapy for treatment of immune disorders
CA2692037A1 (en) * 2007-07-06 2009-01-15 Valorisation Hsj, Societe En Commandite Il-23 receptor antagonists and uses thereof
AR068723A1 (es) * 2007-10-05 2009-12-02 Glaxo Group Ltd Proteina que se une a antigenos que se une a il-23 humana y sus usos
US20100331545A1 (en) 2007-10-24 2010-12-30 Nippon Chemiphar Co., Ltd. Regulator for signaling toll-like receptor, which comprises cathepsin inhibitor as active ingredient
WO2009136286A2 (en) * 2008-05-05 2009-11-12 Novimmune Sa Anti-il-17a/il-17f cross-reactive antibodies and methods of use thereof
US20110158992A1 (en) * 2008-08-27 2011-06-30 Schering Corporation Engineered Anti-IL-23R Antibodies
WO2010036924A2 (en) * 2008-09-25 2010-04-01 The United States Of America, As Represented By The Secretary, Department Of Healthe And Human Serv. Inflammatory genes and microrna-21 as biomarkers for colon cancer prognosis
SI2350316T1 (sl) * 2008-10-20 2014-09-30 Valipharma Postopki in uporabe, ki vkljuäśujejo genetske aberacije nav3 in aberantno izraĺ˝anje veäś genov
US20120128689A1 (en) * 2009-04-01 2012-05-24 Glaxo Group Limited Anti-il-23 immunoglobulins
RU2605318C2 (ru) * 2009-05-05 2016-12-20 Новиммун С.А. Анти-il-17f антитела и способы их применения
EP2456787A4 (en) * 2009-07-24 2013-01-30 Univ Leland Stanford Junior CYTOKINE COMPOSITIONS AND METHODS OF USE
US20110086806A1 (en) * 2009-10-09 2011-04-14 Anaphore, Inc. Polypeptides that Bind IL-23R
JO3244B1 (ar) 2009-10-26 2018-03-08 Amgen Inc بروتينات ربط مستضادات il – 23 البشرية
US20110311527A1 (en) 2010-06-16 2011-12-22 Allergan, Inc. IL23p19 ANTIBODY INHIBITOR FOR TREATING OCULAR AND OTHER CONDITIONS
GEP201706733B (en) 2010-11-04 2017-09-25 Boehringer Ingelheim Int Anti-il-23 antibodies
USRE49026E1 (en) 2011-06-14 2022-04-12 Medical Diagnostic Laboratories, Llc Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof
US8946150B2 (en) 2011-06-14 2015-02-03 Medical Diagnostic Laboratories, LLC. Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof
AU2013256724A1 (en) 2012-05-03 2014-10-30 Boehringer Ingelheim International Gmbh Anti-IL-23p19 antibodies
ES2729603T3 (es) 2012-06-27 2019-11-05 Merck Sharp & Dohme Anticuerpos IL-23 antihumanos cristalinos
UA117466C2 (uk) 2012-12-13 2018-08-10 Мерк Шарп Енд Доме Корп. СТАБІЛЬНИЙ СКЛАД У ВИГЛЯДІ РОЗЧИНУ АНТИТІЛА ДО IL-23p19
JOP20140049B1 (ar) 2013-03-08 2021-08-17 Lilly Co Eli أجسام مضادة ترتبط بـ il-23
EP3708679A1 (en) 2014-07-24 2020-09-16 Boehringer Ingelheim International GmbH Biomarkers useful in the treatment of il-23a related diseases
BR112017004169A2 (pt) 2014-09-03 2017-12-05 Boehringer Ingelheim Int composto direcionado à il-23a e ao tnf-alfa e usos do mesmo
AR102417A1 (es) 2014-11-05 2017-03-01 Lilly Co Eli Anticuerpos biespecíficos anti-tnf- / anti-il-23
CA2979210A1 (en) * 2015-03-11 2016-09-15 Rush University Medical Center Compositions and methods for treating cancer
JP7382232B2 (ja) 2017-05-02 2023-11-16 メルク・シャープ・アンド・ドーム・エルエルシー 抗ｌａｇ３抗体の製剤および抗ｌａｇ３抗体と抗ｐｄ－１抗体との共製剤
JOP20190260A1 (ar) 2017-05-02 2019-10-31 Merck Sharp & Dohme صيغ ثابتة لأجسام مضادة لمستقبل الموت المبرمج 1 (pd-1) وطرق استخدامها
KR20210093973A (ko) 2018-11-20 2021-07-28 얀센 바이오테크 인코포레이티드 항-il23 특이적 항체로 건선을 치료하는 안전하고 효과적인 방법
JP2022534020A (ja) 2019-05-23 2022-07-27 ヤンセン バイオテツク，インコーポレーテツド Ｉｌ－２３及びｔｎｆアルファに対する抗体の併用療法による炎症性腸疾患の治療方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6176962B1 (en) 1990-02-28 2001-01-23 Aclara Biosciences, Inc. Methods for fabricating enclosed microchannel structures
US5552284A (en) 1991-03-29 1996-09-03 Genentech, Inc. Detection of interleukin-8 receptors by nudeic acid hybridization
US6132764A (en) 1994-08-05 2000-10-17 Targesome, Inc. Targeted polymerized liposome diagnostic and treatment agents
AU6501296A (en) 1995-07-21 1997-02-18 General Hospital Corporation, The Method and apparatus of enhancing the delivery of a pharmaceutical formulation
US6056973A (en) 1996-10-11 2000-05-02 Sequus Pharmaceuticals, Inc. Therapeutic liposome composition and method of preparation
US6060284A (en) * 1997-07-25 2000-05-09 Schering Corporation DNA encoding interleukin-B30
US5842787A (en) 1997-10-09 1998-12-01 Caliper Technologies Corporation Microfluidic systems incorporating varied channel dimensions
US6326482B1 (en) 1999-04-23 2001-12-04 Genentech, Inc. SH2 domain-containing peptides
JP2002531466A (ja) 1998-12-01 2002-09-24 プロテイン デザイン ラブス， インコーポレイテッド γ−インターフェロンに対するヒト化抗体
ES2300276T5 (es) * 1999-09-09 2017-06-02 Merck Sharp & Dohme Corp. P40 de interleuquina-12 de mamífero e interleuquina B30. Sus combinaciones. Anticuerpos. Usos en composiciones farmacéuticas
CN101654479A (zh) * 2000-05-10 2010-02-24 先灵公司 哺乳动物细胞因子受体亚单位蛋白、相关试剂及方法
MXPA03002971A (es) * 2000-10-06 2004-05-05 Immunex Corp Receptores de hematopoyetina hpr1 y hpr2.
WO2002097048A2 (en) 2001-05-30 2002-12-05 Centocor, Inc. ANTI-p40 IMMUNOGLOBULIN DERIVED PROTEINS, COMPOSITIONS, METHODS AND USES
WO2004081190A2 (en) * 2003-03-10 2004-09-23 Schering Corporation Uses of il-23 agonists and antagonists; related reagents

Also Published As

Publication number Publication date
DE602004022781D1 (de) 2009-10-08
US20100003251A1 (en) 2010-01-07
HK1076477A1 (en) 2006-01-20
CL2004000467A1 (es) 2005-05-06
AU2010212372A1 (en) 2010-09-09
CY1109468T1 (el) 2014-08-13
WO2004081190A2 (en) 2004-09-23
ZA200506879B (en) 2006-05-31
EP1601694A2 (en) 2005-12-07
TWI439285B (zh) 2014-06-01
AU2004219625B9 (en) 2010-12-23
MXPA05009717A (es) 2005-10-18
US20040223969A1 (en) 2004-11-11
ES2330220T3 (es) 2009-12-07
AU2004219625A1 (en) 2004-09-23
NZ567860A (en) 2009-11-27
CN1759123A (zh) 2006-04-12
WO2004081190A3 (en) 2005-02-03
AU2010212372B2 (en) 2012-12-20
JP4605798B2 (ja) 2011-01-05
CA2518262A1 (en) 2004-09-23
EP2108658A1 (en) 2009-10-14
JP2011032275A (ja) 2011-02-17
US8034341B2 (en) 2011-10-11
TWI357336B (en) 2012-02-01
ATE440864T1 (de) 2009-09-15
US20120034219A1 (en) 2012-02-09
JP2006520781A (ja) 2006-09-14
JP2007197453A (ja) 2007-08-09
NO20054630L (no) 2005-10-07
EP1601694B1 (en) 2009-08-26
PL1601694T3 (pl) 2010-02-26
TW200505479A (en) 2005-02-16
AU2004219625B2 (en) 2010-08-19
NZ541898A (en) 2008-07-31
EP2108658B1 (en) 2016-06-08
NO20054630D0 (no) 2005-10-07
JP2014005286A (ja) 2014-01-16
CA2518262C (en) 2014-05-06
BRPI0408247A (pt) 2006-03-01
SI1601694T1 (sl) 2010-01-29
US7282204B2 (en) 2007-10-16
PT1601694E (pt) 2009-12-03
US20080057058A1 (en) 2008-03-06
CN1759123B (zh) 2011-04-13
TW201141521A (en) 2011-12-01

Similar Documents

Publication Publication Date Title
DK1601694T3 (da) Anvendelser af IL23-antagonister, relaterede reagenser
NO20064193L (no) fremgangsmate for a modulere cytokinaktivitet, beslektede reagenser
CY1108645T1 (el) Θεραπεια και διαγνωση νεοπλασματων χρησιμοποιωντας θυμικη στρωματικη λεμφοποιητινη
BRPI0507794A (pt) métodos de modular a atividade de il-23, reagentes relacionados
BRPI0415361A (pt) antagonistas do receptor muscarìnico de acetilcolina
DK1687049T3 (da) Sprøjter, sprøjtegrænseflader og sprøjtestempler til anvendelse med medicinske injektorer
NO20052496D0 (no) Selekterte CGRP antagonister, fremgangsmater for fremstilling derav og anvendelse derav som medikamenter.
NO20053590D0 (no) Dobbel modusenhet for kortdistanse, hoyrate og langstanse, lavere dataratekommunikasjon.
DE602005011780D1 (de) Triazinderivate mit carbamatfunktion
DE112005002412A5 (de) Kommunikationsgerät, Verfahren zum Bereitstellen von Informationen und diesbezügliche Schnittstelle
IS7441A (is) Peptíðdeformýlasatálmar
ES1051463Y (es) Plantilla anatomico-ortopedica inyectada.
ES1053490Y (es) Plantilla para colocacion de puertas en obra.
ITMI20031904A1 (it) Lampada abbronzante.
ITFI20030259A1 (it) Pigmentatore per la colorazione di pellame e similari.
ES1054423Y (es) Plantilla de calzado almohadillada perfeccionada
SE0302219D0 (sv) Händiga tipset
NL1023104A1 (nl) Menginrichting.
ITGE20020087A1 (it) Facciale per abbronzatura su mobile.
DE502004001309D1 (de) Einrichtung zum Empfang von Verkehrsmeldungen
ITPV20020004A1 (it) Dispositivo per miscelare o amalgamare vernici, pitture o simili.
ES1058723Y (es) Plantillas y elementos correctores terapeuticos a base de aceites esenciales.
ES1055164Y (es) Soporte cuelga-bolsos, perfeccionado.
ATA8972002A (de) Liegeunterlage zur inaktivierung von ektoparasiten
ITMI20022591A1 (it) Compasso.